RESUMEN
Abstract Passiflora nitida Kunth, an Amazonian Passiflora species, is little studied, although the specie's high biological potential. Herein the plant's pharmacognostic characterization, extract production, antioxidant potential evaluation, and application of this extract in cosmetic products is reported. The physical chemical parameters analyzed were particle size by sieve analysis, loss through drying, extractive yield, total ash content, laser granulometry, specific surface area and pore diameter (SBET), differential scanning calorimetry, thermogravimetry (TG), and wave dispersive X-Ray fluorescence (WDXRF). Total phenol/flavonoid content, LC-MS/MS analysis, DPPH and ABTS antioxidant radical assays, cytotoxicity, melanin, and tyrosinase inhibition in melanocytes test provided evidence to determine the content of the major constituent. P. nitida dry extract provided a fine powder with mesopores determined by SBET, with the TG curve showing five stages of mass loss. The antioxidant potential ranged between 23.5-31.5 mgâmL-1 and tyrosinase inhibition between 400-654 µgâmL-1. The species presented an antimelanogenic effect and an inhibitory activity of cellular tyrosinase (26.6%) at 25 µg/mL. The LC-MS/MS analysis of the spray-dried extract displayed the main and minor phenolic compounds constituting this sample. The results indicate that P. nitida extract has promising features for the development of cosmetic formulations
Asunto(s)
Extractos Vegetales/análisis , Hojas de la Planta/efectos adversos , Cosméticos/clasificación , Passiflora/clasificación , Termogravimetría/métodos , Rayos X/efectos adversos , Rastreo Diferencial de Calorimetría/métodos , Monofenol Monooxigenasa/antagonistas & inhibidores , Compuestos Fenólicos , Melaninas , Antioxidantes/efectos adversosRESUMEN
Abstract Because it promotes the lightening of pigment spots, tyrosinase inhibition is one of the mechanisms of depigmenting cosmetic products. Considering the adverse effects produced by synthetic depigmenting actives, the search for new therapeutic options is desirable, and plant extracts are possible candidates for hyperpigmentation treatment. Glycolic extracts of Cecropia pachystachya Trécul are, therefore, the focus of this study. Its chemical characterization, antioxidant activity, tyrosinase inhibition, and cell viability were evaluated. Glycolic extracts were obtained by macerating the leaves of C. pachystachya in grain alcohol and glycerin or propylene glycol. Both had a similar chemical constitution, the glycerin being more efficient in concentrating phenolic compounds and flavonoids. Analyses by UHPLC-MS detected quinic acid, chlorogenic acid isomers, proanthocyanidin dimers type B and C, catechin/epicatechin, orientin/isoorientin, isoorientin 2"-O-xyloside, vitexin/isovitexin, and rutin. 5-O-caffeoylquinic acid was then quantified was then quantified, with predominance in the extract produced with propylene glycol. These extracts showed a high antioxidant capacity by the method of DPPH, ß-carotene, and nitric oxide. As for depigmenting activity, both extracts were able to inhibit tyrosinase. Cell viability assay also revealed that the extracts could safely be used in concentrations of ≤ 125 µg/mL. Thus, this study demonstrated for the first time that the glycolic extracts of C. pachystachya have promising chemical and biological characteristics for the development of a multifunctional cosmetic with antioxidant and tyrosinase-inhibition activities
Asunto(s)
Cosméticos/clasificación , Cecropia/efectos adversos , Blanqueadores/clasificación , Crema para la Piel/análisis , Extractos Vegetales/efectos adversos , Antioxidantes/farmacologíaRESUMEN
A thorough understanding of which of the effects assessed in the in vivo Draize eye test are responsible for driving UN GHS/EU CLP classification is critical for an adequate selection of chemicals to be used in the development and/or evaluation of alternative methods/strategies and for properly assessing their predictive capacity and limitations. For this reason, Cosmetics Europe has compiled a database of Draize data (Draize eye test Reference Database, DRD) from external lists that were created to support past validation activities. This database contains 681 independent in vivo studies on 634 individual chemicals representing a wide range of chemical classes. A description of all the ocular effects observed in vivo, i.e. degree of severity and persistence of corneal opacity (CO), iritis, and/or conjunctiva effects, was added for each individual study in the database, and the studies were categorised according to their UN GHS/EU CLP classification and the main effect driving the classification. An evaluation of the various in vivo drivers of classification compiled in the database was performed to establish which of these are most important from a regulatory point of view. These analyses established that the most important drivers for Cat 1 Classification are (1) CO mean ≥ 3 (days 1-3) (severity) and (2) CO persistence on day 21 in the absence of severity, and those for Cat 2 classification are (3) CO mean ≥ 1 and (4) conjunctival redness mean ≥ 2. Moreover, it is shown that all classifiable effects (including persistence and CO = 4) should be present in ≥60 % of the animals to drive a classification. As a consequence, our analyses suggest the need for a critical revision of the UN GHS/EU CLP decision criteria for the Cat 1 classification of chemicals. Finally, a number of key criteria are identified that should be taken into consideration when selecting reference chemicals for the development, evaluation and/or validation of alternative methods and/or strategies for serious eye damage/eye irritation testing. Most important, the DRD is an invaluable tool for any future activity involving the selection of reference chemicals.
Asunto(s)
Cosméticos/efectos adversos , Cosméticos/clasificación , Evaluación Preclínica de Medicamentos/métodos , Ojo/efectos de los fármacos , Pruebas de Toxicidad/métodos , Animales , Cosméticos/toxicidad , Bases de Datos Factuales , Europa (Continente) , Humanos , Irritantes/clasificación , Irritantes/toxicidad , Conejos , Reproducibilidad de los ResultadosRESUMEN
Abstract Application of sunscreen is the most established method of protecting skin from premature aging and photoaging. In this study, the passion fruit seed extract, enriched with biologically beneficial phenolics, was formulated into sun-protective makeup product. The UVB protection of concealer mousse was found have twofold higher sun protection factor (SPF) than the liquid foundation (15.48 ± 1.60 and 5.88 ± 0.30, respectively). The SPF of concealer mousse as well as the liquid foundation containing 0.1% and 0.3% of the passion fruit seed extract were 18.75 ± 0.28, 18.99 ± 0.71 and 9.32 ± 0.88, 9.77 ± 1.37, respectively. Therefore, the concealers with a similar sun-protective efficacy (p>0.05) were included for stability test accordingly. The sun-protective efficacy did not significantly shift (p>0.05) because the 0.1% and 0.3% passion fruit extract concealers had SPF of 18.09 ± 1.48 and 18.60 ± 1.21. The concealers exhibited UVA photoprotection with a boot star rating of 4 and a critical wavelength wider than 370 nm. The safety of 0.1% passion fruit extract concealer mousse was assessed. It did not cause skin irritation when assessed in human volunteers. This sunscreen makeup product provides UVA and UVB protection and is therefore suitable for daily application.
Asunto(s)
Humanos , Masculino , Femenino , Adulto , Protectores Solares/análisis , Extractos Vegetales/análisis , Passiflora/metabolismo , Semillas/genética , Cosméticos/clasificación , FrutasRESUMEN
ABSTRACT Guava (Psidium guajava L.) is a native fruit of the American tropics with commercial applications for its taste, flavor and aroma. Numerous pharmacological uses have been described for it, such as the antiseptic effect of its leaves, the use of the fresh fruit and tea from its leaves for the treatment of diarrhea, dysentery, diabetes mellitus, and others. However, considering its rich composition, the guava also is a potential source of antioxidants to be used in the development of new formulations for cosmetic and/or dermatological applications, the main focus of this research. Herein, we describe the study of the phytochemical composition and the antioxidant activity of a guava extract prepared with non-toxic solvents aiming its use at biological applications. High performance liquid chromatography and mass spectrometry were employed to identify the major components, while thermoanalytical measurements and hot stage microscopy were used to assess the chemical stability of guava fruit extract. The antioxidant activity was also evaluated assessing the SOD-like activity and ABTS free radical scavenger. The results show that the extract is a rich source of phenolic compounds, such as quercetin, kaempferol, schottenol, among many others. All of the components found in guava extract exhibit biological effects according to the literature data, mainly antioxidant properties.
Asunto(s)
Psidium/química , Dermatología/clasificación , Fitoquímicos/análisis , Antioxidantes/análisis , Extractos Vegetales/farmacología , Cromatografía Líquida de Alta Presión/instrumentación , Cosméticos/clasificaciónRESUMEN
The aim of this work was to evaluate the innovative performance of herbal extracts applied in cosmetics area, based on information collected from Brazilian, American and European patent banks. Analysis were carried out to evaluate the number of patent deposits from each database, the patent applicants profiles, the companies with most patent applications, and also the main uses of herbal extracts in cosmetics. Based on the results achieved, the number of patents filed at the Brazilian patent bank is much lower than that observed in American and European patent banks. Although the number of patents is limited, the analysis indicated a range of cosmetic applications that acts according to the international market trend, represented by a large number of multifunctional products.
O objetivo deste trabalho foi avaliar o cenário da inovação referente a extratos vegetais aplicados no setor de cosméticos, com base em informações extraídas dos bancos de patentes brasileiro, americano e europeu. Foram realizadas análises para avaliar o número de depósitos de patentes de cada banco de dados, o perfil dos depositantes, as empresas com maior número de registros de patentes, e também as principais aplicações dos extratos vegetais descritos nos documentos. Com base nos resultados obtidos, o número de patentes depositadas no banco de patentes brasileiro é muito inferior ao observado nos bancos de patentes americano e europeu. No entanto, embora o número de patentes seja limitado, as análises indicaram uma variedade de aplicações cosméticas que agem de acordo com a tendência do mercado internacional, representada por um número elevado de produtos multifuncionais.
Asunto(s)
Patentes como Asunto , Extractos Vegetales/farmacocinética , Cosméticos/clasificación , Indicadores de PatentesRESUMEN
This paper continues our review of scientifically evaluated plant extracts in dermatology. After plants effective against dermatophytes, botanicals with anti-edema effects in chronic venous insufficiency are discussed. There is good evidence from randomized clinical studies that plant extracts from grape vine leaves (Vitis vinifera), horse chestnut (Aesculus hippocastanum), sea pine (Pinus maritima) and butcher's broom (Ruscus aculeatus) can reduce edema in chronic venous insufficiency. Plant extracts from witch hazel (Hamamelis virginiana), green tea (Camellia sinensis), the fern Polypodium leucotomos and others contain antioxidant polyphenolic compounds that may protect the skin from sunburn and photoaging when administered topically or systemically. Extracts from the garden spurge (Euphorbia peplus) and from birch bark (Betula alba) have been shown to be effective in the treatment of actinic keratoses in phase II studies. Some plant extracts have also been investigated in the treatment of vitiligo, various forms of hair loss and pigmentation disorders, and in aesthetic dermatology.
Asunto(s)
Fármacos Dermatológicos/uso terapéutico , Dermatomicosis/tratamiento farmacológico , Hipotricosis/prevención & control , Queratosis Actínica/tratamiento farmacológico , Extractos Vegetales/uso terapéutico , Insuficiencia Venosa/tratamiento farmacológico , Vitíligo/tratamiento farmacológico , Enfermedad Crónica/prevención & control , Cosméticos/clasificación , Cosméticos/uso terapéutico , Fármacos Dermatológicos/clasificación , Humanos , Extractos Vegetales/clasificación , Protectores Solares/uso terapéuticoRESUMEN
The definition, history, classification and advantages of traditional Chinese medicine cosmetics (TCMC) were summarized in this article. The domestic and foreign current situations of research and development of TCMC were particularly introduced. The application and authorization of TCMC in China were also briefly mentioned. Finally, the developmental prospects of TCMC in China were discussed in two aspects of the strategy of the R&D and the problems facing when it was marketed.